On track to tackle dengue: History and future of NS4B ligands

A recent publication in Nature (Kaptein et al., 2021) reports a highly potent antiviral compound against dengue with promising efficacy in mice. Here, we track the history of this compound class, its pharmacology, and its chemistry, with insights into its potential as orally available drugs to preve...

Full description

Saved in:
Bibliographic Details
Main Authors: Behnam, Mira A. M. (Author) , Klein, Christian D. (Author)
Format: Article (Journal)
Language:English
Published: 8 December 2021
In: Cell host and microbe
Year: 2021, Volume: 29, Issue: 12, Pages: 1735-1737
ISSN:1934-6069
DOI:10.1016/j.chom.2021.11.010
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/j.chom.2021.11.010
Verlag, lizenzpflichtig, Volltext: https://www.sciencedirect.com/science/article/pii/S1931312821005163
Get full text
Author Notes:Mira A.M. Behnam, Christian D. Klein
Description
Summary:A recent publication in Nature (Kaptein et al., 2021) reports a highly potent antiviral compound against dengue with promising efficacy in mice. Here, we track the history of this compound class, its pharmacology, and its chemistry, with insights into its potential as orally available drugs to prevent and treat dengue.
Item Description:Gesehen am 15.02.2022
Physical Description:Online Resource
ISSN:1934-6069
DOI:10.1016/j.chom.2021.11.010